RECRUITING

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

Talk to us

Conditions

Cutaneous T Cell Lymphoma

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.

Official Title

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

Quick Facts

Study Start:2019-01-30
Study Completion:2028-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03932279

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 89 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Group 1: Patients with stage IA-IIA cutaneous T cell lymphoma
  2. * Group 2: Patients with stage IIB and above cutaneous T cell lymphoma
  3. * Group 3: Patients with CD30+ lymphoproliferative disorder including lymphomatoid papulosis and cutaneous anaplastic large cell lymphoma
  4. * Group 4: Patients with plaque psoriasis with BSA\>5% on routine phototherapy per standard of care
  5. * Group 5: Patients with moderate to severe atopic dermatitis on routine bleach bath therapy per standard of care
  6. * Group 6: Healthy individuals without the above skin conditions, similar age and sex distribution to the patients with cutaneous T cell lymphoma
  7. * All Groups: subjects who are age 18-89 years of age at time of enrollment
  8. * All Groups: Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443).
  1. * All Groups: Subjects who are younger than 18 years of age or older than 90 years of age
  2. * All Groups: Subjects who are unable to give consent
  3. * Patients currently on systemic antibiotics or recent (within past 4 weeks) exposure to systemic antibiotics
  4. * We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.

Contacts and Locations

Study Contact

Dermatology CTU
CONTACT
312-503-5944
NUderm-research@northwestern.edu

Principal Investigator

Alan Zhou, MD
PRINCIPAL_INVESTIGATOR
Northwestern University

Study Locations (Sites)

Northwestern University
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Alan Zhou, MD, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-01-30
Study Completion Date2028-08-31

Study Record Updates

Study Start Date2019-01-30
Study Completion Date2028-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cutaneous T Cell Lymphoma